轻症新冠感染6个月后心血管异常的前瞻性病例对照研究
本研究基于COVIDsortium三中心731名医护人员的每周症状、PCR和血清学随访,纳入74例血清阳性与75例年龄性别族裔匹配的血清阴性者,在感染后6个月行综合心脏磁共振及血液标志物检查。结果显示两组在心脏结构、功能、组织特征及生物标志物上均无差异,轻症新冠感染后6个月心血管异常并不更常见。
要点
- 轻症新冠感染后6个月,CMR结构、功能及组织特征与血清阴性对照无差异。
- 报告CMR时应注意T1、T2、LGE等轻度异常在血清阴性人群中同样可见。
- 以2 SD定义的异常阈值下,EF最低50%,LGE中位1%、最大5%心肌。
核心结论
- 轻症SARS-CoV-2感染后6个月,血清阳性与血清阴性健康医护人员的心血管异常发生率无差异。
研究设计与样本
- 三中心前瞻性病例对照研究,源自COVIDsortium对731名医护人员的4个月每周症状、PCR及血清学随访队列。
- 感染后6个月招募74例血清阳性者与75例年龄、性别、族裔匹配的血清阴性对照,共149例受试者。
- 采用体模校准的综合心脏磁共振及血液生物标志物进行心血管表型分析,分析采用盲法并在可行时使用客观人工智能分析。
关键影像表现/征象
- 血清阳性组感染均属轻症:符合病例定义45例(61%)、非病例定义18例(24%)、无症状11例(15%),仅1人住院2天。
- 两组在左室容积、质量、心房面积、射血分数、整体纵向缩短、主动脉扩张性上无差异。
- 两组在T1、T2、细胞外容积分数标测及晚期钆增强等组织特征上无差异。
- 异常定义为低于血清阴性组均值2 SD:EF<54%、室间隔T1>1072 ms、室间隔T2>52.4 ms。
- 异常包括EF降低2例(最低50%)、T1升高6例、T2升高9例、LGE 13例(中位1%,最大5%心肌),两组分布均等。
诊断标准与关键数值
- 异常判定以75例血清阴性对照均值±2 SD为界,如EF<54%、室间隔T1>1072 ms、室间隔T2>52.4 ms。
- 生物标志物异常:4例临界肌钙蛋白升高,所有NT-proBNP均正常。
临床应用与阅片要点
- 阅片报告轻症新冠后CMR时,不应将T1、T2轻度升高或小范围LGE直接归因于既往感染。
- 评估心肌损伤时应结合血清学状态与对照参考值,注意非特异性异常在健康人群中的分布。
局限性
- 样本量较小(149例),仅纳入轻症、以医护人员为主的健康工作人群,结论不能外推至重症或住院患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The purpose of this study was to detect cardiovascular changes after mild severe acute respiratory syndrome-coronavirus-2 infection.
BACKGROUND: Concern exists that mild coronavirus disease 2019 may cause myocardial and vascular disease.
METHODS: Participants were recruited from COVIDsortium, a 3-hospital prospective study of 731 health care workers who underwent first-wave weekly symptom, polymerase chain reaction, and serology assessment over 4 months, with seroconversion in 21.5% (n = 157). At 6 months post-infection, 74 seropositive and 75 age-, sex-, and ethnicity-matched seronegative control subjects were recruited for cardiovascular phenotyping (comprehensive phantom-calibrated cardiovascular magnetic resonance and blood biomarkers). Analysis was blinded, using objective artificial intelligence analytics where available.
RESULTS: A total of 149 subjects (mean age 37 years, range 18 to 63 years, 58% women) were recruited. Seropositive infections had been mild with case definition, noncase definition, and asymptomatic disease in 45 (61%), 18 (24%), and 11 (15%), respectively, with 1 person hospitalized (for 2 days). Between seropositive and seronegative groups, there were no differences in cardiac structure (left ventricular volumes, mass, atrial area), function (ejection fraction, global longitudinal shortening, aortic distensibility), tissue characterization (T1, T2, extracellular volume fraction mapping, late gadolinium enhancement) or biomarkers (troponin, N-terminal pro-B-type natriuretic peptide). With abnormal defined by the 75 seronegatives (2 SDs from mean, e.g., ejection fraction <54%, septal T1 >1,072 ms, septal T2 >52.4 ms), individuals had abnormalities including reduced ejection fraction (n = 2, minimum 50%), T1 elevation (n = 6), T2 elevation (n = 9), late gadolinium enhancement (n = 13, median 1%, max 5% of myocardium), biomarker elevation (borderline troponin elevation in 4; all N-terminal pro-B-type natriuretic peptide normal). These were distributed equally between seropositive and seronegative individuals.
CONCLUSIONS: Cardiovascular abnormalities are no more common in seropositive versus seronegative otherwise healthy, workforce representative individuals 6 months post-mild severe acute respiratory syndrome-coronavirus-2 infection.
引用
- Joy G, Artico J, Kurdi H, et al. Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers. JACC Cardiovasc Imaging. 2021. PMID: 33975819. doi:10.1016/j.jcmg.2021.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。